Financial and Clinical Implications of Intramuscular Versus Subcutaneous Interferon Beta-1a in Portugal, Based on the Findings from the Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis.
Silverio N, Sequeira L, Meletiche D
Value Health. 2014 Nov; 17(7):A396. PMID: 27200931.Abstract